Phenoxybenzamine Derivatives
"Clean Sheets" Pill
- User: Male
- Hormonal: Non-Hormonal
-
Delivery type:
- Undetermined
-
Intended Duration:
- Short-Acting
- Development Stage: Discovery & Early Development
- Developer(s)/researcher(s): King's College, London, CONRAD
Details
- API: Phenoxybenzamine Derivatives
- Target: Undetermined
-
Mechanism of Action:
- Other
- Inactive Materials: Undetermined
- Regimen: On Demand
- MPT: Potential MPT
Product Status
Parsemus Foundation indicates development has ceased
History
Prototypes have been tested successfully in a proof of concept study using rams as an animal model. Test compound successfully triggered anejaculation. Developers subsequently sought support for further development and commercialization.